Influence of the number of high-risk cytogenetic abnormalities on the clinical characteristics and prognosis in 360 patients with newly diagnosed multiple myeloma

被引:0
|
作者
陈智 [1 ]
机构
[1] Dept Hematol,1st Affil Hosp,Nanjing Med Univ
关键词
D O I
暂无
中图分类号
R733.3 [骨髓肿瘤];
学科分类号
摘要
Objective To investigate the influence of the number of high-risk cytogenetic abnormalities (HRCA)on the clinical characteristics and prognosis of patients with newly diagnosed multiple myeloma (MM).Methods A total of 360 patients with newly diagnosed MM admitted to Jiangsu Province Hospital between November 2013 and September 2020 were included in this study. Cytoplasmic light chain immunofluorescence with fluorescence in situ hybridization (cIg-FISH) was used to detect HRCA. Cytogenetic abnormalities were combined with clinical characteristics and outcomes for further analysis. Results Among the 360 patients,120patients (33.3%) didn’t present with HRCAs,and 175(48.6%),61 (16.9%),and four (1.1%) patients had one, two, and three HRCA (s), respectively.
引用
收藏
页码:182 / 183
页数:2
相关论文
共 50 条
  • [21] LECULAR CYTOGENETIC TECHNIQUES IN IDENTIFICATION OF GENETIC ABNORMALITIES AMONG NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Al-Maeen, Abdul Rahman
    Al-Majed, Mohammed
    Khojah, Osamah
    Al-Khayat, Adnan
    Al-Harbi, Ahmed
    Al-Balwi, Mohammed
    Al-Atawi, Nasser
    Al-Suhaibani, Ahmed
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 5 - 5
  • [22] Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Wang, Huijuan
    Li, Yanchen
    Leng, Yun
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [23] Cell Free MYC DNA Copy Number Identifies High-Risk Smouldering Myeloma and Newly Diagnosed Multiple Myeloma
    Wong, Daniel
    Reynold, John
    Wellard, Cameron
    Bingham, Nicholas
    Zhao, Jessie
    Ramachandran, Malarmathy
    Quach, Hang
    Gibbs, Simon
    Khong, Tiffany T.
    Mithraprabhu, Sridurga
    Spencer, Andrew
    BLOOD, 2023, 142
  • [24] High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience
    Rodriguez-Otero, Paula
    Gonzalez-Calle, Veronica
    Calasanz, Maria-Jose
    Cedena, Teresa
    Puig, Noemi
    Martinez-Lopez, Joaquin
    Rosinol, Laura
    Hernandez Garcia, Miguel Teodoro
    Isabel Teruel, Ana
    Gironella, Mercedes
    Oriol, Albert
    de la Rubia, Javier
    Pilar Gonzalez-Rodriguez, Ana
    Bargay, Joan
    de Arriba de la Fuente, Felipe
    Palomera, Luis
    Gonzalez-Perez, Marta-Sonia
    Sureda Balari, Anna
    Lahuerta Palacios, Juan Jose
    Blade, Joan
    San-Miguel, Jesus
    Mateos, Maria-Victoria
    Gutierrez, Norma
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S241 - S242
  • [25] High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience
    Gonzalez-Calle, Veronica
    Rodriguez-Otero, Paula
    Calasanz, Maria J.
    Guijarro, Manuela
    Martinez-Lopez, Joaquin
    Rosinol, Laura
    Hernandez, Miguel T.
    Teruel, Ana I.
    Gironella, Mercedes
    Oriol, Albert
    de la Rubia, Javier
    Gonzalez-Rodriguez, Ana P.
    Bargay, Joan
    de Arriba, Felipe
    Palomera, Luis
    Gonzalez-Perez, Marta-Sonia
    Sureda, Anna
    Ocio, Enrique
    Lahuerta, Juan J.
    Blade, Joan
    San Miguel, Jesus F.
    Mateos, Maria V.
    Gutierrez, Norma C.
    HEMASPHERE, 2024, 8 (12):
  • [26] Cytogenetic and clinical risk factors for assessment of ultra high-risk multiple myeloma
    Zhuang, Junling
    Da, Yi
    Li, Hui
    Han, Bing
    Wan, Xia
    Zhu, Tienan
    Chen, Miao
    Duan, Minghui
    Xu, Ying
    Zhao, Yongqiang
    Shen, Ti
    Wu, Yongji
    Zhou, Daobin
    LEUKEMIA RESEARCH, 2014, 38 (02) : 188 - 193
  • [27] Total therapies (TT) for newly diagnosed patients with multiple myeloma (MM): Significant benefit in high-risk disease with cytogenetic abnormalities (CA) over the course of 17 years.
    van Rhee, Frits
    Bolejack, Vanessa
    Anaissie, Elias
    Tricot, Guido
    Hollmig, Klaus
    Zangari, Maurizio
    Pineda-Roman, Mauricio
    Mohiuddin, Abid
    Hoering, Antje
    Crowley, John
    Barlogie, Bart
    BLOOD, 2006, 108 (11) : 995A - 995A
  • [28] Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma
    Mao, Xuehan
    Xu, Yan
    Yan, Yuting
    Liu, Jiahui
    Fan, Huishou
    Sui, Weiwei
    Deng, Shuhui
    Li, Zengjun
    Qiu, Lugui
    An, Gang
    BLOOD, 2019, 134
  • [29] Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma
    Mohyuddin, Ghulam Rehman
    Abdallah, Al-Ola
    McClune, Brian
    JAMA ONCOLOGY, 2021, 7 (04) : 635 - 635
  • [30] Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma
    Auwerda, Johannes J. A.
    Sonneveld, Pieter
    de Maat, Monica P. M.
    Leebeek, Frank W. G.
    HAEMATOLOGICA, 2007, 92 (02) : 279 - 280